| Literature DB >> 36017501 |
Taha Alqahtani1, Rekha Khandia2, Nidhi Puranik2, Ali M Alqahtani1, Kumarappan Chidambaram1, Mohammad Amjad Kamal3,4,5,6.
Abstract
Dementia is a clinical syndrome characterized by progressive cognitive decline, and the symptoms could be gradual, persistent, and progressive. In the present study, we investigated 47 genes that have been linked to dementia. Compositional, selectional, and mutational forces were seen to be involved. Nucleotide components that influenced A- and GC-affected codon usages bias at all three codon positions. The influence of these two compositional constraints on codon usage bias (CUB) was positive for nucleotide A and negative for GC. Nucleotide A also experienced the highest mutational force, and GC-ending codons were preferred over AT-ending codons. A high bias toward GC-ending codons enhances the gene expression level, evidenced by the positive association between CAI- and GC-ending codons. Unusual behavior of the TTG codon showing an inverse relationship with the GC-ending codon and negative influence of gene expression, behavior contrary to all other GC-ending codons, shows an operative selectional force. Furthermore, parity analysis, higher translational selection value, preference of GC-ending codons over AT-ending codons, and association of gene length with gene expression refer to the dominant role of selection pressure with compositional constraint and mutational force-shaping codon usage.Entities:
Keywords: GC composition; codon usage; compositional constraint; dementia; nucleotide skew
Year: 2022 PMID: 36017501 PMCID: PMC9395603 DOI: 10.3389/fgene.2022.884348
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.772
Gene associated with dementia.
| S.No | Gene | Accession number | Synonyms | Location on chromosome | Disease associated with malfunctional gene | Function/s |
|---|---|---|---|---|---|---|
| 1 | ALS2 (Alsin Rho guanine nucleotide exchange factor) | NG_008775.1 | ALSJ; PLSJ; IAHSP; ALS2CR6 | 2q33.1 | Juvenile Amyotrophic Lateral Sclerosis | Functions as a guanine nucleotide exchange factor for the small GTPase RAB5 |
| 2 | ANG (angiogenin) | NG_008717.2 | ALS9, HEL168, RAA1, RNASE4, RNASE5 | 14q11.2 | Amyotrophic Lateral Sclerosis 1 | A potent mediator of new blood vessel formation |
| 3 | APP (amyloid beta precursor protein) | NG_007376.2 | AAA, ABETA, ABPP, AD1, APPI, CTF gamma, CVAP, PN-II, PN2, alpha-sAPP, preA4 | 21q21.3 | Alzheimer Disease | Have bactericidal and antifungal activities |
| 4 | C19orf12 (chromosome 19 open reading frame 12) | NG_031970.2 | MPAN; NBIA3; NBIA4; SPG43 | 19q12 | Neurodegeneration with Brain Iron Accumulation | Mutations in this gene are a cause of neurodegeneration with brain iron accumulation-4 (NBIA4) |
| 5 | C9orf72 (C9orf72-SMCR8 complex subunit) | NG_031977_2 | ALSFTD, DENND9, DENNL72, FTDALS, FTDALS1 | 9p21.2 | Amyotrophic Lateral Sclerosis 1 | Plays an important role in the regulation of endosomal trafficking |
| 6 | CHCHD10 (coiled-coil-helix-coiled-coil-helix domain containing 10) | NG_034223_1 | IMMD; SMAJ; MIX17A; FTDALS2; N27C7-4; C22orf16 | 22q11.23 | Frontotemporal Dementia and/or Amyotrophic Lateral Sclerosis 2 | Role in cristae morphology maintenance or oxidative phosphorylation |
| 7 | CHMP2B (charged multivesicular body protein 2B) | NG_007885_1 | DMT1; ALS17; VPS2B; VPS2-2; CHMP2.5; FTDALS7 | 3p11.2 | Amyotrophic Lateral Sclerosis 1 | Functions in the recycling or degradation of cell surface receptors |
| 8 | CLCN3 (chloride voltage-gated channel 3) | NG_029731_1 | CLC3; ClC-3 | 4q33 | Cystic Fibrosis | Essential for lysophosphatidic acid (LPA)-activated Cl- current activity and fibroblast-to-myofibroblast differentiation |
| 9 | CLCN5 (chloride voltage-gated channel 5) | NG_007159_3 | XRN; CLC5; XLRH; CLCK2; ClC-5; DENT1; DENTS; NPHL1; NPHL2; hCIC-K2 | Xp11.23 | Hypophosphatemic Rickets, X-Linked Recessive | Facilitate albumin uptake by the renal proximal tubule |
| 10 | CP (ceruloplasmin) | NG_011800_3 | CP-2 | 3q24-q25.1 |
| It binds most of the copper in plasma and is involved in the peroxidation of Fe(II) transferrin to Fe(III) transferrin |
| 11 | CTSD (cathepsin D) | NG_012303_2 | CPSD; CLN10; HEL-S-130P | 11p15.5 | Alzheimer Disease | It exhibits pepsin-like activity and plays a role in protein turnover and in the proteolytic activation of hormones and growth factors |
| 12 | CTSF (cathepsin F) | NG_008655_1 | CATSF; CLN13 | 11q13.2 | Adult Neuronal Ceroid Lipofuscinosis | Targeted to the endosomal/lysosomal compartment via the mannose 6-phosphate receptor pathway |
| 13 | EIF4G1 (eukaryotic translation initiation factor 4 gamma 1) | NG_032973_1 | P220; EIF4F; EIF4G; EIF4GI; PARK18; EIF-4G1 | 3q27.1 | Parkinson Disease 18, Autosomal Dominant | Facilitates the recruitment of mRNA to the ribosome |
| 14 | ERBB4 (erb-b2 receptor tyrosine kinase 4) | NG_016850_1 | HER4; ALS19; p180erbB4 | 2q34 | Amyotrophic Lateral Sclerosis 19 | Binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation |
| 15 | FUS (FUS RNA binding protein) | NG_011805_2 | ALS6, ETM4, FUS1, HNRNPP2, POMP75, TLS, altFUS | 16p11.2 | Frontotemporal Dementia and/or Amyotrophic Lateral Sclerosis 1 | This protein belongs to the FET family of RNA-binding proteins, which have been implicated in cellular processes that include the regulation of gene expression, maintenance of genomic integrity, and mRNA/microRNA processing |
| 16 | GRN (granulin precursor) | NG_012889_2 | GEP; GP88; PEPI; PGRN; CLN11; PCDGF | 17q21.31 | Grn-Related Frontotemporal Lobar Degeneration | It regulates cell growth |
| 17 | HNRNPA1 (heterogeneous nuclear ribonucleoprotein A1) | NG_007886_1 | ALS19, ALS20, HNRPA1, HNRPA1L3, IBMPFD3, UP 1, hnRNP A1, hnRNP-A1 | 12q13.13 | Amyotrophic Lateral Sclerosis 1 | Plays a key role in the regulation of alternative splicing |
| 18 | ITM2B (integral membrane protein 2B) | NG_033830_1 | BRI; FBD; ABRI; BRI2; E25B; E3-16; RDGCA; imBRI2; BRICD2B | 13q14.2 | Cerebral Amyloid Angiopathy, Itm2b-Related, 2 | Inhibits the deposition of beta-amyloid |
| 19 | MAPT (microtubule-associated protein tau) | NG_013069_2 | DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, PPP1R103, TAU, tau-40 | 17q21.31 | Parkinson–Dementia Syndrome | Regulates alternative splicing, giving rise to several mRNA species |
| 20 | NOTCH3 (notch receptor 3) | NG_007398_2 | IMF2; LMNS; CASIL; CADASIL; CADASIL1 | 19p13.12 | Lateral Meningocele Syndrome | Plays a key role in neural development |
| 21 | NPC1 (NPC intracellular cholesterol transporter 1) | NG_009819_1 | NPC, POGZ, SLC65A1 | 18q11.2 | Niemann–Pick Disease, Type C1 | Transports low-density lipoproteins to late endosomal/lysosomal compartments |
| 22 | NPC2 (NPC intracellular cholesterol transporter 2) | NG_012795_1 | HE1; EDDM1 | 14q24.3 | Niemann–Pick Disease, Type C2 | The encoded protein may function in regulating the transport of cholesterol through the late endosomal/lysosomal system |
| 23 | CSF1R (colony-stimulating factor 1 receptor) | NG_007117_1 | BANDDOS, C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R | 5q32 | Leukoencephalopathy | Controls the production, differentiation, and function of macrophages |
| 24 | OPTN (optineurin) | NG_012876_1 | ALS12, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP | 10p13 | Amyotrophic Lateral Sclerosis | Functions in cellular morphogenesis and membrane trafficking, vesicle trafficking, and transcription activation |
| 25 | PDGFB (platelet-derived growth factor subunit B) | NG_012111_1 | SIS; SSV; IBGC5; PDGF2; c-sis; PDGF-2 | 22q13.1 | Dermatofibrosarcoma Protuberans | These proteins bind and activate PDGF receptor tyrosine kinases, which play a role in a wide range of developmental processes |
| 26 | PDGFRB (platelet-derived growth factor receptor beta) | NG_023367_1 | IMF1; KOGS; IBGC4; JTK12; PDGFR; PENTT; CD140B; PDGFR1; PDGFR-1 | 5q32 | Infantile myofibromatosis | This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton |
| 27 | PPT1 (palmitoyl-protein thioesterase 1) | NG_009192_1 | PPT; CLN1; INCL | 1p34.2 | Neuronal Ceroid Lipofuscinosis | Enzyme removes thioester-linked fatty acyl groups such as palmitate from cysteine residues |
| 28 | PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta) | NG_042811_1 | PRKAR1 | 7p22.3 | Prkar1b-Related Neurodegenerative Dementia with Intermediate Filaments | Involved in many cellular events including ion transport, metabolism, and transcription |
| 29 | PRNP (prion protein) | NG_009087_1 | ASCR, AltPrP, CD230, CJD, GSS, KURU, PRIP, PrP, PrP27-30, PrP33-35C, PrPc, p27-30 | 20p13 | Huntington disease-like 1 | Mutations in the repeat region as well as elsewhere in this gene have been associated with the Creutzfeldt–Jakob disease, fatal familial insomnia, Gerstmann–Straussler disease, and kuru |
| 30 | PSEN1 (presenilin 1) | NG_007386_2 | AD3; FAD; PS1; PS-1; S182; ACNINV3 | 14q24.2 | Alzheimer Disease 3 | Presenilins are involved in the cleavage of the Notch receptor |
| 31 | PSEN2 (presenilin 2) | NG_007381_2 | AD4; PS2; AD3L; STM2; CMD1V | 1q42.13 | Alzheimer Disease 4 | This is involved in the cleavage of the Notch receptor in a way that they either directly regulate gamma-secretase activity or themselves act as protease enzymes |
| 32 | SERPINI1 (serpin family I member 1) | NG_008217_1 | PI12; HNS-S1; HNS-S2; neuroserpin | 3q26.1 | Dementia, Alzheimer Disease | Plays a role in the regulation of axonal growth and the development of synaptic plasticity |
| 33 | SETX (senataxin) | NG_007946_1 | ALS4; AOA2; Sen1; SCAN2; SCAR1; bA479K20.2 | 9q34.13 | Amyotrophic Lateral Sclerosis 4, Juvenile | Involved in both DNA and RNA processing |
| 34 | SIGMAR1 (sigma non-opioid intracellular receptor 1) | NG_029945_2 | SRBP; ALS16; DSMA2; OPRS1; SR-BP; SIG-1R; SR-BP1; sigma1R; hSigmaR1 | 9p13.3 | Juvenile Amyotrophic Lateral Sclerosis | Plays an important role in the cellular functions of various tissues associated with the endocrine, immune, and nervous systems |
| 35 | SNCA (synuclein alpha) | NG_011851_1 | NACP, PARK1, PARK4, PD1 | 4q22.1 | Parkinson Disease 1, Autosomal Dominant | Inhibits phospholipase D2 selectively; serves to integrate presynaptic signaling and membrane trafficking |
| 36 | SNCB (synuclein beta) | NG_012131_1 | Synuclein beta | 5q35.2 | Dementia, Lewy Body | It inhibits phospholipase D2 and may function in neuronal plasticity |
| 37 | SOD1 (superoxide dismutase 1) | NG_008689_1 | ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP, hSod1, homodimer | 21q22.11 | Amyotrophic Lateral Sclerosis 1 | SOD1 contains an antimicrobial peptide that displays antibacterial, antifungal, and anti-MRSA activities |
| 38 | SORL1 (sortilin related receptor 1) | NG_023313_1 | C11orf32, LR11, LRP9, SORLA, SorLA-1, gp250 | 11q24.1 | Alzheimer Disease | Plays roles in endocytosis and sorting |
| 39 | SPG11 (SPG11 vesicle trafficking associated, spatacsin) | NG_007117_1 | ALS5; CMT2X; KIAA1840 | 15q21.1 | Juvenile Amyotrophic Lateral Sclerosis | Potential transmembrane protein that is phosphorylated upon DNA damage |
| 40 | SQSTM1 (sequestosome 1) | NG_011342_1 | p60; p62; A170; DMRV; OSIL; PDB3; ZIP3; p62B; NADGP; FTDALS3 | 5q35.3 | Sporadic and familial Paget disease of bone | Protein functions as a scaffolding/adaptor protein i |
| 41 | TARDBP (TAR DNA binding protein) | NG_008734_1 | ALS10, TDP-43 | 1p36.22 | Amyotrophic Lateral Sclerosis 10 with or Without Frontotemporal Dementia | Regulates alternate splicing of the CFTR gene |
| 42 | TREM2 (triggering receptor expressed on myeloid cells 2) | NG_011561_1 | PLOSL2; TREM-2; Trem2a; Trem2b; Trem2c | 6p21.1 | Alzheimer Disease | Functions in immune response and may be involved in chronic inflammation by triggering the production of constitutive inflammatory cytokines |
| 43 | TYROBP (transmembrane immune signaling adaptor TYROBP) | NG_009304_1 | DAP12; KARAP; PLOSL; PLOSL1 | 19q13.12 |
| It associates with the killer-cell inhibitory receptor (KIR) family of membrane glycoproteins and may act as an activating signal transduction element |
| 44 | UBQLN2 (ubiquilin 2) | NG_016249_1 | DSK2; ALS15; CHAP1; N4BP4; PLIC2; HRIHFB2157 | Xp11.21 | Amyotrophic Lateral Sclerosis 1 | Functionally links the ubiquitination machinery to the proteasome to affect |
| 45 | VCP (valosin containing protein) | NG_007887_1 | CDC48, FTDALS6, TERA, p97 | 9p13.3 | Amyotrophic Lateral Sclerosis 1 | The encoded protein plays a role in protein degradation, intracellular membrane fusion, DNA repair and replication, regulation of the cell cycle, and activation of the NF-kappa B pathway |
| 46 | VPS13A (vacuolar protein sorting 13 homolog A) | NG_008931_1 | CHAC, CHOREIN | 9q21.2 | Choreoacanthocytosis | It may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes, and the plasma membrane |
| 47 | XPR1 (xenotropic and polytropic retrovirus receptor 1) | NG_050964_1 | X3; SYG1; IBGC6; SLC53A1 | 1q25.3 | Basal Ganglia Calcification, Idiopathic, 6 | Involved in phosphate homeostasis by mediating phosphate export from the cell |
FIGURE 1A nucleotide compositional analysis figure shows the trend of the compositional constraints. The nucleotide contents are sorted here as per their increasing values and do not depict their content in a single gene.
Correlation between nucleotide compositions and CUB.
| %A | %A1 | %A2 | %A3 | %T | %T1 | %T2 | |
|---|---|---|---|---|---|---|---|
| Pearson (r) | 0.411 | 0.374 | 0.450 | 0.299 | 0.460 | 0.384 | 0.052 |
|
| ** | ** | ** | * | ** | ** | NS |
| %T3 | %C | %C1 | %C2 | %C3 | %G | %G1 | |
| Pearson (r) | 0.479 | −0.306 | −0.266 | −0.288 | −0.233 | −0.581 | −0.332 |
|
| *** | * | NS | * | NS | *** | * |
| %G2 | %G3 | %GC | %GC1 | %GC2 | %GC3 | %GC3s | |
| Pearson (r) | −0.188 | −0.531 | −0.501 | −0.548 | −0.342 | −0.414 | −0.419 |
|
| NS | *** | *** | *** | * | ** | ** |
***p< 0.001. **p < 0.01, *p < 0.05, NS, Non-significant.
FIGURE 2Correlation analysis of RSCU values of a codon and CAI value. A positive correlation is blue circles, while a negative correlation is depicted as red circles. The level of significance was at 0.05%.
CAI values of the genes envisaged in the study.
| S.No. | Gene | CAI | Gene | CAI | Gene | CAI | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ALS2 | 0.719 | 17 | GRN | 0.828 | 33 | SETX | 0.705 |
| 2 | ANG | 0.784 | 18 | HNRNPA1 | 0.771 | 34 | SIGMAR1 | 0.788 |
| 3 | APP | 0.787 | 19 | ITM2B | 0.759 | 35 | SNCA | 0.762 |
| 4 | C19orf12 | 0.796 | 20 | MAPT | 0.797 | 36 | SNCB | 0.803 |
| 5 | C9orf72 | 0.686 | 21 | NOTCH3 | 0.813 | 37 | SOD1 | 0.774 |
| 6 | CHCHD10 | 0.812 | 22 | NPC1 | 0.756 | 38 | SORL1 | 0.793 |
| 7 | CHMP2B | 0.694 | 23 | NPC2 | 0.719 | 39 | SPG11 | 0.721 |
| 8 | CLCN3 | 0.709 | 24 | OPTN | 0.748 | 40 | SQSTM1 | 0.8 |
| 9 | CLCN5 | 0.732 | 25 | PDGFB | 0.819 | 41 | TARDBP | 0.74 |
| 10 | CP | 0.743 | 26 | PDGFRB | 0.816 | 42 | TREM2 | 0.804 |
| 11 | CSF1R | 0.829 | 27 | PPT1 | 0.74 | 43 | TYROBP | 0.759 |
| 12 | CTSD | 0.849 | 28 | PRKAR1B | 0.826 | 44 | UBQLN2 | 0.744 |
| 13 | CTSF | 0.817 | 29 | PRNP | 0.798 | 45 | VCP | 0.77 |
| 14 | EIF4G1 | 0.772 | 30 | PSEN1 | 0.719 | 46 | VPS13A | 0.673 |
| 15 | ERBB4 | 0.759 | 31 | PSEN2 | 0.808 | 47 | XPR1 | 0.742 |
| 16 | FUS | 0.782 | 32 | SERPINI1 | 0.717 | — | — | — |
FIGURE 3A cluster analyses of multivariate data showed the clustering of TTG with AT-ending codons.
FIGURE 4Regression analysis between GC3 and RSCU of codons CGT, AGG, CTA, and CTG.
Effect of compositional constraints on selective codons.
| GC3 compositional constraint effect | ||||
|---|---|---|---|---|
| CGT | AGG | CTG | CTA | |
| Pearson correlation (r) | −0.08583 | 0.14005 | 0.79525 | −0.62947 |
| Regression coefficient (r2) | 0.0073 | 0.019613 | 0.63242 | 0.39623 |
|
| NS | NS | <0.0001 | <0.0001 |
| Slope | −0.002 | 0.007 | 0.0553 | −0.113 |
| Intercept | 0.721 | 0.765 | −0.729 | 1.037 |
| AT3 compositional constraint effect | ||||
| Pearson correlation (r) | 0.0858 | −0.1400 | −0.7952 | 0.6294 |
| Regression coefficient (r2) | 0.0073 | 0.0196 | 0.6324 | 0.3962 |
|
| NS | NS | <0.0001 | <0.0001 |
| Slope | 0.0023 | -0.007 | -0.553 | 0.0113 |
| Intercept | 0.490 | 1.553 | 4.801 | −0.1003 |
NS- Non-significant ***-p<0.0001.
FIGURE 5Regression plot analysis between GC3 and GC12 exhibiting the mutational and selection forces.
FIGURE 6Determination of the effect of mutational force on composition by regression analysis.